摘要
《新型冠状病毒肺炎诊疗方案(试行第七版)》新增托珠单抗的免疫治疗方案。本文对托珠单抗治疗新冠肺炎的合理使用及药学监护进行论述,以期为临床提供参考。
Tocilizumab was recommended in the"Novel Coronavirus Pneumonia Diagnosis and Treatment Scheme( Trial version 7.0)".In this paper,the rational use of tocilizumab in the treatment of COVID-19 pneumonia and pharmaceutical care are discussed in order to provide a reference for clinical practice.
作者
梁虹艺
万宁
林伟斌
季波
LIANG Hongyi;WAN Ning;LIN Weibin;JI Bo(General Hospital of Southern Theatre Command,Guangzhou 510010,China;Army Supports Pharmacy Staff of Hubei Medical Team,Wuhan 430000,China)
出处
《广东药科大学学报》
CAS
2020年第3期388-391,402,共5页
Journal of Guangdong Pharmaceutical University